Brazilian AIDS group joins tenofovir opposition in India
This article was originally published in Scrip
Executive Summary
The Brazilian Interdisciplinary AIDS Association (ABIA) and the Indian NGO Sahara (Centre for Residential Care and Rehabilitation) have opposedGilead Sciences' patent application for the reverse transcriptase inhibitor tenofovir in India.